Preoperative albumin-bilirubin score is a prognostic factor for gastric cancer patients after curative gastrectomy

Table 5 Univariate and multivariate analysis for overall survival

Overall survival	Univariate			Multivariate
Variables	HR	95%CI	P value	HR	95%CI	P value
Male (vs female)	1.20	0.85-1.71	0.306	-	-	-
Age > 65 yr (vs < 65 yr)	1.28	0.94-1.79	0.137	-	-	-
Charlson > 1 (vs 0)	1.42	1.02-1.98	0.041	1.25	0.83-1.89	0.282
ASA III/IV (vs ASA I/II)	1.94	1.35-2.80	< 0.001	1.60	1.02-2.52	0.041
Total gastrectomy (vs distal)	1.50	1.08-2.08	0.016	1.56	1.12-2.18	0.009
Diffuse/mixed (vs others)	1.29	0.93-1.79	0.133	-	-	-
pT3/T4 (vs pT1/T2)	2.44	1.65-3.61	< 0.001	1.87	1.20-2.91	0.006
pN+ (vs pN0)	2.24	1.57-3.20	< 0.001	1.58	1.06-2.37	0.026
non-CMT (vs CMT)	1.18	0.85-1.64	0.327	-	-	-
Low-ALBI (vs High-ALBI)	1.97	1.41-2.74	< 0.001	1.68	1.20-2.35	0.003

P values in bold are statistically significant. 95%CI: 95% confidence interval; HR: Hazard ratio; ASA: American Society of Anesthesiologists; ALBI: Albumin-bilirubin; pN: Presence of lymph node metastasis; CMT: Chemotherapy.